NHANES I | 73 | 2.19 (1.98 to 2.42) | 1.28 (1.20 to 1.38) | 1.11 (1.04 to 1.18) | 1.33 (1.11 to 1.59) | 2.17 (1.60 to 2.94) |
NHANES II | 78 | 2.84 (2.39 to 3.37) | 1.28 (1.16 to 1.43) | 1.12 (1.01 to 1.25) | 2.03 (1.57 to 2.64) | 1.73 (1.15 to 2.60) |
Framingham cohort | 80 | 2.12 (1.81 to 2.48) | 1.34 (1.17 to 1.53) | 1.22 (1.07 to 1.40) | 1.37 (1.03 to 1.82) | 1.99 (1.23 to 3.21) |
Tecumseh community health study | 81 | 2.48 (2.10 to 2.94) | 1.46 (1.28 to 1.67) | 1.32 (1.14 to 1.53) | 1.86 (1.32 to 2.63) | 1.85 (0.94 to 3.66) |
Honolulu heart program | 80 | 2.12 (1.73 to 2.60) | 1.59 (1.45 to 1.75) | 1.39 (1.25 to 1.55) | 2.02 (1.61 to 2.55) | 2.85 (2.17 to 3.75) |
Puerto Rico heart health program | | | | | | |
Urban | 76 | 2.01 (1.63 to 2.49) | 1.56 (1.43 to 1.70) | 1.27 (1.16 to 1.40) | 1.43 (1.10 to 1.87) | 2.88 (2.07 to 4.03) |
Rural | 77 | 2.23 (1.56 to 3.19) | 1.66 (1.43 to 1.94) | 1.15 (0.95 to 1.41) | 1.44 (0.92 to 2.25) | 2.86 (1.23 to 6.60) |
Yugoslavia cardiovascular disease study | | | | | |
Urban | 82 | 2.11 (1.64 to 2.71) | 1.56 (1.35 to 1.80) | 1.33 (1.16 to 1.52) | 1.54 (1.03 to 2.30) | 4.63 (2.15 to 9.96) |
Rural | 82 | 2.20 (1.58 to 3.06) | 1.81 (1.49 to 2.20) | 0.86 (0.67 to 1.10) | 2.05 (1.13 to 3.71) | |
Scottish collaborative study | 75 | 2.03 (1.77 to 2.32) | 1.45 (1.34 to 1.56) | 1.28 (1.19 to 1.38) | 1.90 (1.61 to 2.25) | 1.65 (0.78 to 3.51) |
Renfrew and Paisley study | 68 | 2.13 (1.90 to 2.40) | 1.31 (1.24 to 1.37) | 1.18 (1.11 to 1.26) | 1.58 (1.39 to 1.79) | 2.73 (1.93 to 3.87) |
Glostrup cohort | 77 | 2.09 (1.67 to 2.61) | 1.53 (1.28 to 1.83) | 1.20 (1.05 to 1.38) | 2.09 (1.38 to 3.16) | 2.52 (1.26 to 5.02) |
Norwegian counties study | 73 | 2.25 (1.88 to 2.69) | 1.54 (1.43 to 1.65) | 1.29 (1.24 to 1.34) | 2.55 (2.18 to 2.98) | 3.98 (2.62 to 6.03) |
Iceland Reykjavik study | 75 | 2.36 (2.13 to 2.61) | 1.40 (1.31 to 1.50) | 1.34 (1.25 to 1.44) | 1.75 (1.49 to 2.05) | 1.78 (1.17 to 2.71) |
Israeli ischemic heart disease study | 79 | 2.08 (1.88 to 2.31) | 1.51 (1.43 to 1.60) | 1.33 (1.24 to 1.42) | 1.56 (1.35 to 1.79) | 2.31 (1.86 to 2.87) |
Lipid research clinics follow-up study | | | | | |
Random sample | 83 | 2.50 (1.92 to 3.26) | 1.40 (1.13 to 1.72) | 1.40 (1.10 to 1.77) | 1.91 (1.18 to 3.09) | 8.05 (3.80 to 17.03) |
Hyperlipidaemic | 79 | 2.39 (1.85 to 3.09) | 1.17 (0.92 to 1.50) | 1.27 (1.16 to 1.39) | 1.82 (1.11 to 2.99) | 3.79 (1.60 to 8.98) |
HDFP (regular care) | 73 | 1.95 (1.56 to 2.44) | 1.31 (1.13 to 1.52) | 1.12 (0.99 to 1.25) | 1.60 (1.14 to 2.25) | 1.79 (1.06 to 3.05) |
MRFIT (usual care) | 66 | 1.74 (1.37 to 2.20) | 1.41 (1.19 to 1.66) | 1.22 (1.06 to 1.41) | 2.02 (1.51 to 2.71) | 1.24 (0.61 to 2.51) |